We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Revises Hotline Ad Study in Response to Industry Input
FDA Revises Hotline Ad Study in Response to Industry Input
August 21, 2009
The FDA will expand a study of TV drug advertising to determine the effectiveness of listing a consumer hotline for reporting adverse events, based on drug industry comments.